an-affordable-hiv-1-drug-resistance-monitoring-method-for-resource

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

HIV-1 drug resistance has the potential to seriously compromise the effectiveness and impact of antiretroviral therapy (ART). As ART programs in ...

University of KwaZulu-Natal, Durban, South Africa

There is an urgent need to assess the accuracy/feasibility of using dried blood spots (DBS) for monitoring of HIV-1 viral load in resource-limited settings. A total of 892 DBS from HIV-1-positive pregnant women and their neonates enrolled in the Kesho Bora prevention of mother-to-child transmission trial conducted in Durban (South Africa) and Bobo-Dioulasso (Burkina Faso) between May 2005 and July 2008 were tested for HIV-1 RNA. The combination Nuclisens extraction method (BioMérieux)/Generic HIV Viral Load assay (Biocentric) was performed using one DBS (in Durban) versus 2 DBS (in Bobo-Dioulasso) on 2 distinct open real-time polymerase chain reaction instruments. DBS HIV-1 RNA results were compared with plasma HIV-1 RNA and HIV serology results used as the gold standards. The limits of detection of assays on DBS were 3100 and 1550 copies per milliliter in Durban and Bobo-Dioulasso, respectively. DBS HIV-1 RNA values correlated significantly with plasma levels (n = 327; R = 0.7351) and were uniformly distributed according to duration of DBS storage at -20°C (median duration, 280 days). For early infant diagnosis, the sensitivity and specificity were 100% (95% confidence interval: 97.2 to 100.0 and 96.5 to 100.0, respectively). HIV-1 viral load kinetics in DNase-pretreated DBS were similar to those obtained in plasma specimens among 13 patients receiving antiretroviral treatment. HIV-1 RNA findings from serial infant DBS collected prospectively (n = 164) showed 100% concordance with HIV serology at 18 months of life. Our findings strongly advocate the implementation of DBS HIV-1 RNA testing in remote areas from low-income and middle-income countries.

Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso.

Better understanding of drug resistance patterns in HIV-infected children on antiretroviral therapy (ART) is required to inform public health policies in high prevalence settings. The aim of this study was to characterise the acquired drug resistance in HIV-infected children failing first-line ART in a decentralised rural HIV programme.

Sureshnee Pillay

Africa Centre for Health and Population Studies,
College of Health Sciences,
Africa Centre for Health and Population Studies, College of Health Sciences

University of KwaZulu-Natal, Durban, South Africa

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Sureshnee Pillay

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Africa Centre for Health and Population Studies,College of Health Sciences,Africa Centre for Health and Population Studies, College of Health Sciences

University of KwaZulu-Natal, Durban, South Africa

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Africa Centre for Health and Population Studies,
College of Health Sciences,
Africa Centre for Health and Population Studies, College of Health Sciences